^
    Apply
    PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer (NCT01899599)
    Phase 2
    Glycotope GmbH
    Completed
    Last update posted :
    10/22/2020
    Initiation :
    09/01/2013
    Primary completion :
    04/20/2017
    Completion :
    07/28/2017
    MUC16
    |
    TA-MUC1 positive
    |
    PankoMab-GEX (gatipotuzumab)